A. Menzies-Gow Et Al. , "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study," The Lancet Respiratory Medicine , vol.11, no.5, pp.425-438, 2023
Menzies-Gow, A. Et Al. 2023. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. The Lancet Respiratory Medicine , vol.11, no.5 , 425-438.
Menzies-Gow, A., Wechsler, M. E., Brightling, C. E., Korn, S., Corren, J., Israel, E., ... Chupp, G.(2023). Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. The Lancet Respiratory Medicine , vol.11, no.5, 425-438.
Menzies-Gow, Andrew Et Al. "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study," The Lancet Respiratory Medicine , vol.11, no.5, 425-438, 2023
Menzies-Gow, Andrew Et Al. "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study." The Lancet Respiratory Medicine , vol.11, no.5, pp.425-438, 2023
Menzies-Gow, A. Et Al. (2023) . "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study." The Lancet Respiratory Medicine , vol.11, no.5, pp.425-438.
@article{article, author={Andrew Menzies-Gow Et Al. }, title={Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study}, journal={The Lancet Respiratory Medicine}, year=2023, pages={425-438} }